These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. [Chronic left heart ventricle failure and inotropic stimulation]. Myhre ES; Gundersen T; Dickstein K; Hole T; Kjekshus J; Rønnevik P; Smith P; Westheim A Tidsskr Nor Laegeforen; 1995 Jan; 115(3):360-4. PubMed ID: 7855836 [TBL] [Abstract][Full Text] [Related]
64. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects]. Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348 [TBL] [Abstract][Full Text] [Related]
65. Effect of vasodilator and inotropic drugs on clinical symptoms and long-term survival in chronic congestive heart failure. Packer M Eur Heart J; 1988 Jun; 9 Suppl H():105-8. PubMed ID: 2901957 [TBL] [Abstract][Full Text] [Related]
66. New treatment strategies in patients with impaired left ventricular systolic function. Part II: Treatment of moderate to severe cardiac dysfunction. Rozo JC; Barry WL; Stouffer GA Am J Med Sci; 1999 May; 317(5):312-7. PubMed ID: 10334119 [No Abstract] [Full Text] [Related]
67. [Programs for continuing medical education: B session; 1. The pathophysiology of heart failure--is it the disease of the heart?]. Kitakaze M Nihon Naika Gakkai Zasshi; 2014 Mar; 103(3):681-6. PubMed ID: 24796136 [No Abstract] [Full Text] [Related]
71. Pharmacological treatment of hypertrophic cardiomyopathy: current practice and novel perspectives. Ammirati E; Contri R; Coppini R; Cecchi F; Frigerio M; Olivotto I Eur J Heart Fail; 2016 Sep; 18(9):1106-18. PubMed ID: 27109894 [TBL] [Abstract][Full Text] [Related]
72. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy. Mallick A; Gandhi PU; Gaggin HK; Ibrahim N; Januzzi JL JACC Heart Fail; 2016 Sep; 4(9):749-55. PubMed ID: 27179830 [TBL] [Abstract][Full Text] [Related]
73. Recommended Heart Failure Medications and Adverse Drug Reactions in Women. Bots SH; den Ruijter HM Circulation; 2019 Mar; 139(12):1469-1471. PubMed ID: 30883224 [No Abstract] [Full Text] [Related]
74. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons. Aronow WS J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528 [TBL] [Abstract][Full Text] [Related]
75. Medical therapy of heart failure with reduced ejection fraction: current evidence and new developments. Naegele M; Flammer AJ; Enseleit F; Ruschitzka F Swiss Med Wkly; 2016; 146():w14295. PubMed ID: 26968014 [TBL] [Abstract][Full Text] [Related]
76. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF. Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP; Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403 [TBL] [Abstract][Full Text] [Related]
77. Comparison of losartan and captopril in ELITE II. Meyer FP Lancet; 2000 Sep; 356(9232):851; author reply 852-3. PubMed ID: 11022947 [No Abstract] [Full Text] [Related]
79. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study. Pitt B; Latini R; Maggioni AP; Solomon SD; Smith BA; Wright M; Prescott MF; McMurray JJ Eur J Heart Fail; 2011 Jul; 13(7):755-64. PubMed ID: 21467028 [TBL] [Abstract][Full Text] [Related]
80. Impacts of person-centred integrated chronic heart failure and palliative home care on pharmacological heart failure treatment: a substudy of a randomised trial. Markgren R; Brännström M; Lundgren C; Boman K BMJ Support Palliat Care; 2019 Mar; 9(1):e10. PubMed ID: 26792391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]